Document is current
Any future updates will be listed below
-
Authors
Millard, S. K. http://orcid.org/0000-0002-5205-636X
Murphy, S.
Barton, G.
Leathersich, M.
Mills, G.
Rixon, L.
Shepstone, L.
Sims, E.
Joffe, V.
-
Funding
Funding for this research was provided by:
Research for Patient Benefit Programme (PB-PG-0817-20045)
- License Information
-
More Information
Article History
Received: 8 December 2021
Accepted: 24 August 2022
First Online: 16 September 2022
Declarations
:
: Ethical approval was obtained from London – Bloomsbury Research Ethics Committee, REC ref. 19/LO/0933; IRAS: 251914. All participants will provide informed written consent and in the case of children their parents will provide consent on their behalf. The trial will be conducted in accordance with the principles of the Declaration of Helsinki (1996) and the principles of Good Clinical Practice (GCP). The chief investigator is required to submit regular reports and a final report at conclusion of the trial to NIHR, the funder. The current report reports protocol version 5. All amendments are to be approved and disseminated to sites, NIHR, Sponsor, researchers and monitoring groups.
: Not applicable—this manuscript does not contain data from any individual person.
: Sharon Millard works at the Centre where Palin STSC(8–14) was developed and contributed to the development of the therapy programme. The other authors declare that they have no competing interests.
